| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE | 13 |
| 1 | METHOTREXATE SODIUM | 13 |
| 2 | ADALIMUMAB | 10 |
| 3 | FUROSEMIDE | 8 |
| 4 | INFLIXIMAB | 7 |
| 5 | ETOPOSIDE | 6 |
| 6 | PANTOPRAZOLE SODIUM | 6 |
| 7 | PREDNISONE | 6 |
| 8 | CARBOPLATIN | 5 |
| 9 | FLUOROURACIL | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM ACETATE | 4 | 0.0027 |
| 1 | PALIFERMIN | 1 | 0.0026 |
| 2 | AMIFOSTINE | 1 | 0.0012 |
| 3 | BUPRENORPHINE HCL | 1 | 0.0011 |
| 4 | SODIUM CHLORIDE 0.65% | 1 | 0.0007 |
| 5 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 1 | 0.0005 |
| 6 | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE | 1 | 0.0005 |
| 7 | CARMUSTINE | 2 | 0.0004 |
| 8 | TREOSULFAN | 1 | 0.0004 |
| 9 | 1168 BURN SPRAY | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 13 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 13 |
| 2 | Platinum-based Drug [EPC] | 13 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 9 |
| 5 | Loop Diuretic [EPC] | 8 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 7 |
| 7 | Alkylating Drug [EPC] | 6 |
| 8 | Topoisomerase Inhibitor [EPC] | 6 |
| 9 | Opioid Agonist [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | Antimalarial [EPC] | 1 | 0.0001 |
| 2 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 3 | Topoisomerase Inhibitor [EPC] | 6 | 0.0001 |
| 4 | Platinum-based Drug [EPC] | 13 | 0.0000 |
| 5 | Intestinal Lipase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Progesterone [EPC] | 1 | 0.0000 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 13 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 7 | 0.0000 |
| 9 | Polyene Antifungal [EPC] | 1 | 0.0000 |